copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Long-Acting Injectables (LAIs) | National Alliance on Mental . . . Long-acting injectables (LAIs) are Injectable medications used for individuals living with mental illness 1, 2 LAIs are usually the same medication that is taken in pill form but when injected they allow for the slow release of medication into the blood over a longer period of time 1,2 LAIs include: Abilify Maintena®, Aristada®, fluphenazine d
A Practical Review of Long-Acting Injectable Antipsychotics ABSTRACT: Long-acting injectable (LAI) antipsychotics are an important treatment option to help improve adherence in patients with schizophrenia and schizoaffective disorder LAI antipsychotics are managed and dosed differently than oral antipsychotics
Long-Acting Injectable Antipsychotics (LAIs) - PsychDB Long-Acting Injectable (LAI) Antipsychotics are antipsychotics delivered via intramuscular injection that can provide medication coverage from a period of weeks to months Once stabilized on an LAI, patients rarely will need oral antipsychotic supplementation
Psychotropic LAI Training Program | aapp. org This ACPE approved educational activity includes 5 hours of on demand recorded webinars on psychotropic LAI patient selection, pharmacology, dosing, preparation administration storage, key adverse effects and mitigation strategies, and building an LAI practice
Guidelines for the use and management of long-acting . . . LAI antipsychotics are indicated in patients with schizophrenia, schizoaffective disorder, delusional disorder and bipolar disorder LAI second-generation antipsychotics are recommended as maintenance treatment after the first episode of schizophrenia
Long-Acting Injectable (LAI) Medication - Provider Express When treating schizophrenia, the medication assessment should include the use of the long-acting injectable (LAI) formulations of antipsychotic medication; consideration should include patient age, preferences and or a history of poor or uncertain adherence (source: American Psychiatric Association)